Found 5 matching trials
MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
PHASE1The purpose of this study is evaluate the safety and tolerability of MPH966...
Location
Duke University Adult Bone Marrow Transplant Clinic
A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.
PHASE2The purpose of this study is to investigate the effect of alvelestat (an or...
Location
University of Alabama, Birmingham (UAB)
COVID-19 Study of Safety and Tolerability of Alvelestat
PHASE1The purpose of this study is to determine the safety, tolerability and phar...
Location
UAB Lung Health Center
Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
PHASE1Background:
Bronchiolitis obliterans syndrome (BOS) is a complication peop...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency
PHASE2This is a Phase 2, multicenter, double-blind, randomized (1:1), placebo-con...
Location
The University of Alabama at Birmingham Lung Health Center